Human histone demethylase LSD1 reads the histone code

被引:197
|
作者
Forneris, F
Binda, C
Vanoni, MA
Battaglioli, E
Mattevi, A
机构
[1] Univ Milan, Dipartimento Biol & Genet Sci Med, I-20133 Milan, Italy
[2] Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy
[3] Univ Milan, Dipartimento Sci Biomol & Biotecnol, I-20133 Milan, Italy
关键词
D O I
10.1074/jbc.M509549200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human histone demethylase LSD1 is a flavin-dependent amine oxidase that catalyzes the specific removal of methyl groups from mono- and dimethylated Lys(4) of histone H3. The N-terminal tail of H3 is subject to various covalent modifications, and a fundamental question in LSD1 biology is how these epigenetic marks affect the demethylase activity. We show that LSD1 does not have a strong preference for mono- or dimethylated Lys(4) of H3. Substrate recognition is not confined to the residues neighboring Lys(4), but it requires a sufficiently long peptide segment consisting of the N-terminal 20 amino acids of H3. Electrostatic interactions are an important factor in protein-substrate recognition, as indicated by the high sensitivity of Km to ionic strength. We have probed LSD1 for its ability to demethylate Lys4 in presence of a second modification on the same peptide substrate. Methylation of Lys(9) does not affect enzyme catalysis. Conversely, Lys9 acetylation causes an almost 6-fold increase in the Km value, whereas phosphorylation of Ser(10) totally abolishes activity. LSD1 is inhibited by a demethylated peptide with an inhibition constant of 1.8 mu M, suggesting that LSD1 can bind to H3 independently of Lys(4) methylation. LSD1 is a chromatin-modifying enzyme, which is able to read different epigenetic marks on the histone N-terminal tail and can serve as a docking module for the stabilization of the associated corepressor complex(es) on chromatin.
引用
收藏
页码:41360 / 41365
页数:6
相关论文
共 50 条
  • [21] Histone Demethylase LSD1 Regulates Osteoblast Differentiation in vitro and in vivo
    Rummukainen, Petri
    Tarkkonen, Kati
    Al-Majidi, Rana
    Dudakovic, Amel
    van Wijnen, Andre
    Valensisi, Cristina
    Hawkins, David
    Kiviranta, Riku
    JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 : 231 - 232
  • [22] Histone demethylase LSD1 controls the phenotypic plasticity of cancer cells
    Hino, Shinjiro
    Kohrogi, Kensaku
    Nakao, Mitsuyoshi
    CANCER SCIENCE, 2016, 107 (09): : 1187 - 1192
  • [23] Tetrahydropyridine derivatives: Novel and potent histone demethylase LSD1 inhibitors
    Callery, Patrick S.
    Wichitnithad, Wisut
    Borysiewicz, Elizabeth
    Konat, Gregory W.
    Konat, Gregory W.
    CANCER RESEARCH, 2011, 71
  • [24] Uncoupling histone modification crosstalk by engineering lysine demethylase LSD1
    Lee, Kwangwoon
    Barone, Marco
    Waterbury, Amanda L.
    Jiang, Hanjie
    Nam, Eunju
    DuBois-Coyne, Sarah E.
    Whedon, Samuel D.
    Wang, Zhipeng A.
    Caroli, Jonatan
    Neal, Katherine
    Ibeabuchi, Brian
    Dhoondia, Zuzer
    Kuroda, Mitzi I.
    Liau, Brian B.
    Beck, Samuel
    Mattevi, Andrea
    Cole, Philip A.
    NATURE CHEMICAL BIOLOGY, 2025, 21 (02) : 227 - 237
  • [25] Isoprenaline Inhibits Histone Demethylase LSD1 to Induce Cardiac Hypertrophy
    Wu, Lili
    Yang, Bo
    Sun, Yingze
    Fan, Guanwei
    Ma, Lina
    Ma, Ying
    Xiong, Xianjia
    Zhou, Hui
    Wang, Huiping
    Zhang, Ling
    Yang, Bing
    CARDIOVASCULAR TOXICOLOGY, 2025, 25 (01) : 34 - 47
  • [26] Regulation of LSD1 histone demethylase activity by its associated factors
    Shi, YJ
    Matson, C
    Lan, F
    Iwase, S
    Baba, T
    Shi, Y
    MOLECULAR CELL, 2005, 19 (06) : 857 - 864
  • [27] Histone Demethylase LSD1 Regulates Neural Stem Cell Proliferation
    Sun, GuoQiang
    Alzayady, Kamil
    Stewart, Richard
    Ye, Peng
    Yang, Su
    Li, Wendong
    Shi, Yanhong
    MOLECULAR AND CELLULAR BIOLOGY, 2010, 30 (08) : 1997 - 2005
  • [28] Targeting Histone Demethylase LSD1/KDM1a in Neurodegenerative Diseases
    Ambrosio, Susanna
    Majello, Barbara
    JOURNAL OF EXPERIMENTAL NEUROSCIENCE, 2018, 12
  • [29] The histone demethylase LSD1/KDM1A as therapeutic target in AML
    Berg, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 272 - +
  • [30] Structural basis for CoREST-dependent demethylation of nucleosomes by the human LSD1 histone demethylase
    Yang, Maojun
    Gocke, Christian B.
    Luo, Xuelian
    Borek, Dominika
    Tomchick, Diana R.
    Machius, Mischa
    Otwinowski, Zbyszek
    Yu, Hongtao
    MOLECULAR CELL, 2006, 23 (03) : 377 - 387